Texas Capital initiated coverage of Cinemark (CNK) with a Buy rating and $31 price target The firm says domestic box office revenues are “primed for a solid double-digit percent increase” in 2025 as the post-pandemic recovery continues. The exhibitors have the potential to return to pre-pandemic adjusted EBITDA levels by 2026, even if total industry attendance remains below pre-pandemic levels, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK:
- Short Report: Bears look to Cinemark, Dave & Busters to reflect growth scare
- Cinemark Holdings: Positioned for Growth with Strategic Pricing, Enhanced Offerings, and Strong Financial Strategies
- Cinemark Holdings Signs New Agreement with Marketing Leader
- Cineworld taps advisers for IPO or potential merger, Bloomberg reports
- Morgan Stanley lowers Cinemark price target, sees ‘compelling opportunity’
Questions or Comments about the article? Write to editor@tipranks.com